Week in Review
FDA releases new COVID-19 vaccine guidelines, EPA gives Oklahoma authority over environmental programs on tribal lands, and more…
My Body, Whose Choice?
States should require doctors to seek informed consent before performing pelvic exams on anesthetized women.
Reflecting on a Decade of The Regulatory Review
The Review’s Editors-in-Chief reflect on their experiences and celebrate what makes this publication so extraordinary.
Innovation and Securities Regulation
The SEC should do more to support the use of innovative technologies by investors in capital markets.
The Evolution of Delaware’s Corporate Oversight Doctrine
Recent court decisions have set the stage for greater board accountability for corporate regulatory noncompliance.
The Crisis Pregnancy Center Conundrum
Experts call for crisis pregnancy center regulation to combat free speech concerns and medical misinformation.
Week in Review
Democrats propose a new coronavirus relief bill, a federal judge rejects the Trump Administration’s TikTok ban, and more…
Antitrust and Regulation Over Time
As the scope of regulation in an industry narrows, the scope of potential antitrust liability becomes broader.
Remembering and Continuing RBG’s Legacy
Justice Ginsburg paved the way toward gender equality, inspiring generations to advocate justice under the law.
A Decade of Political Swings, and Consistency
Presidential administrations have taken dramatically different approaches to regulation over the last ten years.
The Art of the Climate Change War
The world needs a new strategy to fight climate change aggressively and effectively.
Hidden in Plain Sight: Why Regulations Need a Fresh Look
Distinguished lecturer discusses restoring public support for regulation and how regulatory benefits are hidden in plain sight.